COM:POSEIDA
Poseida Therapeutics, Inc.
- Stock
Last Close
2.72
21/11 21:00
Market Cap
288.93M
Beta: -
Volume Today
296.17K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
net income | -19.66M - | -44.40M 125.84% | -86.53M 94.86% | -129.78M 49.98% | -124.97M 3.70% | -64.00M 48.79% | -123.43M 92.85% | |
depreciation and amortization | 676K - | 689K 1.92% | 1.19M 73.15% | 2.59M 116.76% | 4.55M 76.02% | 5.17M 13.62% | 5.61M 8.55% | |
deferred income tax | -528K - | -202K 61.74% | 784K 488.12% | 213K 72.83% | -19.63M 9,316.90% | -1.11M - | ||
stock based compensation | 400K - | 975K 143.75% | 3.05M 212.82% | 7.22M 136.72% | 16.70M 131.36% | 18.93M 13.30% | 23.13M 22.23% | |
change in working capital | -1.85M - | 718K 138.79% | 9.47M 1,218.52% | 5.62M 40.60% | 20.17M 258.67% | 13.71M 32.00% | 1.11M 91.87% | |
accounts receivables | 865K - | -9.09M - | 77K 100.85% | |||||
inventory | -124K - | |||||||
accounts payables | -41K - | 1.00M 2,548.78% | 1.53M 52.39% | -4.17M 372.61% | 7.84M 288.01% | -6.75M 186.05% | 1.04M 115.38% | |
other working capital | -2.55M - | -286K 88.79% | 7.94M 2,875.17% | 9.79M 23.40% | 12.33M 25.85% | 29.55M 139.75% | -1.11M 103.77% | |
other non cash items | -1.73M - | 4.21M 343.07% | 7.64M 81.54% | 805K 89.47% | 639K 20.62% | -583K 191.24% | 2.52M 531.39% | |
net cash provided by operating activities | -22.70M - | -38.01M 67.48% | -64.39M 69.38% | -113.33M 76.00% | -102.54M 9.52% | -26.77M 73.89% | -92.17M 244.27% | |
investments in property plant and equipment | -201K - | -1.28M 538.81% | -5.16M 301.56% | -16.91M 227.93% | -2.63M 84.42% | -3.92M 48.97% | -3.07M 21.87% | |
acquisitions net | 37.31M - | 187.52M 402.63% | 18K 99.99% | 12K 33.33% | ||||
purchases of investments | -71.44M - | -295.02M 312.99% | -18K 99.99% | -294.42M 1,635,577.78% | -237.80M 19.23% | |||
sales maturities of investments | 34M - | 107.50M 216.18% | 225M 109.30% | 95M 57.78% | 280M 194.74% | |||
other investing activites | -37.31M - | -187.52M 402.63% | 18K 100.01% | |||||
net cash used for investing activites | -201K - | -1.28M 538.81% | -42.59M 3,217.13% | -204.43M 379.98% | 222.38M 208.78% | -203.33M 191.43% | 39.13M 119.25% | |
debt repayment | -9.95M - | -1.45K - | ||||||
common stock issued | 149.78M - | 205.74M 37.36% | 2.52M 98.78% | 75.30M 2,890.43% | 1.28M 98.31% | |||
common stock repurchased | ||||||||
dividends paid | ||||||||
other financing activites | 20.63M - | 54.07M 162.08% | 24.54M 54.62% | 108.20M 340.98% | 29.86M - | 14.85M 50.27% | ||
net cash used provided by financing activities | 20.63M - | 54.07M 162.08% | 164.37M 204.01% | 313.94M 91.00% | 2.52M 99.20% | 105.16M 4,076.29% | 16.13M 84.66% | |
effect of forex changes on cash | 1K - | |||||||
net change in cash | -2.27M - | 14.77M 751.52% | 57.39M 288.55% | -3.82M 106.65% | 122.36M 3,304.79% | -124.95M 202.12% | -36.91M 70.46% | |
cash at beginning of period | 17.89M - | 15.63M 12.67% | 30.39M 94.53% | 87.78M 188.81% | 83.97M 4.35% | 206.32M 145.72% | 81.38M 60.56% | |
cash at end of period | 15.63M - | 30.39M 94.53% | 87.78M 188.81% | 83.97M 4.35% | 206.32M 145.72% | 81.38M 60.56% | 44.47M 45.35% | |
operating cash flow | -22.70M - | -38.01M 67.48% | -64.39M 69.38% | -113.33M 76.00% | -102.54M 9.52% | -26.77M 73.89% | -92.17M 244.27% | |
capital expenditure | -201K - | -1.28M 538.81% | -5.16M 301.56% | -16.91M 227.93% | -2.63M 84.42% | -3.92M 48.97% | -3.07M 21.87% | |
free cash flow | -22.90M - | -39.30M 71.62% | -69.55M 76.97% | -130.24M 87.27% | -105.18M 19.24% | -30.70M 70.81% | -95.23M 210.25% |
All numbers in (except ratios and percentages)